Advisor Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Advisor Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$6K	Sell	108 -22	-17%	-$1.09K	﹤0.01%	4628
2019 Q3	$5K	Sell	130 -6	-4%	-$253	﹤0.01%	4714
2019 Q2	$6K	Buy	136 +10	+8%	+$564	﹤0.01%	4644
2019 Q1	$6K	Sell	126 -43	-25%	-$1.86K	﹤0.01%	4645
2018 Q4	$6K	Sell	169 -3	-2%	-$108	﹤0.01%	4483
2018 Q3	$6K	Sell	172 -1	-0.6%	-$37	﹤0.01%	4556
2018 Q2	$7K	Sell	173 -9	-5%	-$286	﹤0.01%	4290
2018 Q1	$5K	Sell	182 -4	-2%	-$120	﹤0.01%	4470
2017 Q4	$5K	Hold	186	–	–	﹤0.01%	4468
2017 Q3	$7K	Buy	186 +66	+55%	+$2K	﹤0.01%	4174
2017 Q2	$3K	Buy	+120	New	+$2.76K	﹤0.01%	4484

Other funds holding BHVN

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Advisor Group's BHVN Position: Q4 2019 in Review

Advisor Group reduced its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 17% in Q4 2019, selling an estimated $1.09K and leaving 108 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Advisor Group first reported a position in BHVN in Q2 2017 and has held it in 11 quarters since. The position peaked at $7K in Q2 2018. 188 funds tracked by Wall St. Rank hold BHVN as of Q4 2019.

Advisor Group held 108 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $6K as of Q4 2019.
Advisor Group sold 22 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2019, an estimated $1.09K.
Biohaven Pharmaceutical Holding Company Ltd. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4628 holding.
Advisor Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and has held it in 11 quarters since.
Advisor Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7K in Q2 2018.
188 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.